HOME › Press Releases › Pyrogen Testing Market worth 1086.3 Million USD by 2021
Pyrogen Testing Market worth 1086.3 Million USD by 2021
The report "Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis.
Browse 74 market data Tables and 95 Figures spread through 173 Pages and in-depth TOC on "Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, Lal, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021"
Early buyers will receive 10% customization on reports.
The global Pyrogen Testing market was valued at USD 610.2 Million in 2016. This market is expected to grow at a CAGR of 12.2% to reach USD 1086.3 Million in 2021.
The global pyrogen testing market is segmented on the basis of applications, products, tests, and geographies. By application, the market is divided into pharmaceuticals and biologicals manufacturing, medical devices manufacturing, and other applications such as water purification, food and beverages, cosmetics, and plastics and glass products. Of these, the pharmaceuticals and biologicals manufacturing segment accounted for the largest share of the global pyrogen testing market in 2016. The large share of this segment can primarily be attributed to the rapid growth in pharmaceutical and biotechnology industries.
The test segments included in this report are in vitro pyrogen test, LAL (Limulus Amebocyte Lysate) test, and Rabbit test. Of these the LAL (Limulus amebocyte lysate) test holds the highest share. The large share of LAL test can primarily be attributed to its advantages such as accuracy, speed, requirement of small amount of the tested sample, more economical, and allows detection of lower level of endotoxins, and flexibility in life science research. The LAL test is further sub-segmented in to chromogenic tests, turbidimetric tests, and gel clot tests.
The product segments included in the report are kits and reagents, services, and Instruments. The kits & reagents segment commanded the largest share of global pyrogen testing market. The large share of this segment can mainly be attributed to repeat purchase of kits and reagents as compared to instruments, and increasing adoption of kit-based testing.
Rapidly increasing pharmaceutical and biotechnology industries and increasing number of new biologics products launched will be the two most important growth drivers for this market during the forecast period. For instance, the number of new biologics products launched annually witnessed a strong upward trend between 2003 and 2013. The number of new products launched in 2013 was 56 as compared to 29 in 2003. The biologics pipeline has increased by 155%, from 355 treatments in 2001 to 907 in 2012. A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industry, which is an important application of pyrogen testing products.
The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada; Europe is further segmented into France, Germany, Italy, Spain, the U.K., and the Rest of Europe (RoE); Asia is further segmented into China, Japan, and India, and the Rest of Asia; and the Rest of the World (RoW) is divided into Africa, Pacific and Oceania, and South America, Central America, and the Caribbean.
Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.) Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc. (China).
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India